Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Myriad Genetics' MPC-7869 stabilizes PSA levels in phase II

May 2, 2001

Lilly claims new use of parathyroid hormone

April 30, 2001

IntaBiotics' Protegrin IB-367 rinse meets secondary but not primary endpoints

April 30, 2001

MX-2060: a novel caspase-activating apoptosis inducer discovered at Maxim

April 30, 2001

Aventis prepares oxindoles as potent inhibitors of cyclin-dependent kinases

April 30, 2001

PhotoCure seeks marketing approval for Metvix(R) PDT in New Zealand

April 30, 2001

Indena focuses on modulators of MDR

April 27, 2001

Novel calpain protease discovered by Millennium team

April 27, 2001

Ovarian cancer vaccines prepared at Corixa

April 27, 2001

Beta-sheet-forming peptide designed as novel antiangiogenic agent

April 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...